Formulation and Evaluation of the Pregabalin Immediate Release Microencapsulation Beadlets
Abstract
Pregabalin is an effective drug used in the management of neuropathic pain and epilepsy; however, its conventional dosage forms may require frequent administration. The present study aimed to develop and evaluate pregabalin microencapsulated beadlets as a multiparticulate drug-delivery system capable of providing controlled drug release. Pregabalin beadlets were prepared using suitable encapsulation and pelletization techniques with selected pharmaceutical excipients. The prepared formulations were evaluated for percentage yield, particle size, flow properties, drug content, entrapment efficiency, surface characteristics, and in-vitro drug-release behavior. Fourier-transform infrared spectroscopy (FTIR) was performed to assess drug–excipient compatibility, and the characteristic peaks of pregabalin were retained in the physical mixture without significant changes, indicating compatibility. Among the developed formulations, the optimized formulation exhibited satisfactory physical characteristics, high drug content, and a controlled drug-release profile. The optimized formulation showed approximately 98% drug release over 12 h, demonstrating a gradual and sustained release pattern. The in-vitro release data were fitted to zero-order, first-order, Higuchi, and Korsmeyer–Peppas kinetic models. The Korsmeyer–Peppas model showed the highest correlation coefficient (R² = 0.982), suggesting that diffusion played a major role in drug release. Stability studies under accelerated conditions (40 ± 2°C/75 ± 5% RH) showed no significant changes in physical appearance, drug content, or drug-release characteristics during the study period. Overall, the developed pregabalin microencapsulated beadlets demonstrated satisfactory formulation characteristics and sustained drug-release behavior, indicating their potential as a multiparticulate controlled-release dosage form.
Keywords: Microencapsulated beadlets; FTIR; Pregabalin; Korsmeyer–Peppas; Higuchi.
Keywords:
Microencapsulated beadlets, FTIR, Pregabalin, Korsmeyer–Peppas, HiguchiDOI
https://doi.org/10.22270/jddt.v16i11.8052References
1. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007; 73 (2):137-150. https://doi.org/10.1016/j.eplepsyres.2006.09.008 PMid:17126531
2. Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 2007; 28 (2):75-82. https://doi.org/10.1016/j.tips.2006.12.006 PMid:17222465
3. National Library of Medicine. Pregabalin capsules: prescribing information. Bethesda (MD): National Library of Medicine; 2025.
4. Shukla B, Sharma A, Gastroretentive Floating Microspheres of Metaxalone: A Novel Drug Delivery Approach for Muscle Relaxation. Journal of Drug Delivery and Therapeutics, 2025;15(11):31-44. https://doi.org/10.22270/jddt.v15i11.7407
5. Yan C, Kim SR. Microencapsulation for pharmaceutical applications: a review. ACS Appl Bio Mater. 2024; 7(2):692-710. https://doi.org/10.1021/acsabm.3c00776 PMid:38320297
6. Sharma RB, Tomar S, Kaushal S, Kaur A. the Role of Multiscale Approaches for the Rational Design of Nanoparticulate Drug Delivery System: Recent Advances. Computational Drug Delivery; IGI Global Scientific Publishing: Hershey, PA, USA. 2024 Oct 7:19-38. https://doi.org/10.1515/9783111208671-002
7. Singh J, Sharma RB, Mehan N, Beniwal SK. Itraconazole-loaded nanocrystals development and characterization for the treatment of ophthalmic fungal infection. Lat Am J Pharm. 2023 Jul 19;42(3):839-47.
8. Rahman MA, Ahuja A, Baboota S, Bhavna, Bali V, Saigal N, et al. Recent advances in pelletization technique for oral drug delivery: a review. Curr Drug Deliv. 2009; 6 (1):122-129. https://doi.org/10.2174/156720109787048339 PMid:19418964
9. Sharma RB, Kumar A, Gupta A. Development And Evaluation Of Nanospheres Containing Carbimazole. Int J App Pharm. 2023;15 (6):264-268. https://doi.org/10.22159/ijap.2023v15i6.48966
10. Baner S, Sharma RB. Development and evaluation of terbinafine-loaded nanosponges. Int J Pharm Sci Rev Res. 2023; 82 (2):162-166. https://doi.org/10.47583/ijpsrr.2023.v82i02.023
11. Sharma M, Dhiman N, Singh P, Sharma R, Sharma RB, Arora V, Arora S. Gel incorporated lipid nanoparticles for the treatment of psoriasis. Materials Today: Proceedings. 2022 Jan 1; 48: 1690-1701. https://doi.org/10.1016/j.matpr.2021.10.023
12. Handattu MS, Thirumaleshwar S, Prakash GM, Somareddy HK, Veerabhadrappa GH. A comprehensive review on pellets as a dosage form in pharmaceuticals. Curr Drug Deliv. 2021; 18 (10):1183-1195. https://doi.org/10.2174/1389450122999210120204248 PMid:33475056
13. Kállai-Szabó N, Farkas D, Lengyel M, Basa B, Fleck C, Antal I. Microparticles and multi-unit systems for advanced drug delivery. Eur J Pharm Sci. 2024; 194: 106704. https://doi.org/10.1016/j.ejps.2024.106704 PMid:38228279
14. Ghebre-Sellassie I, editor. Pharmaceutical Pelletization Technology. New York: Marcel Dekker; 1989.
15. Sinha VR, Agrawal MK, Agarwal A, Singh G, Ghai D. Extrusion-spheronization: process variables and characterization. Crit Rev Ther Drug Carrier Syst. 2009;26 (3):275-331. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i3.20 PMid:19799528
16. Quality aspects in the development of pelletized dosage forms. Heliyon. 2022;8(2):e08956. https://doi.org/10.1016/j.heliyon.2022.e08956 PMid:35243077 PMCid:PMC8873546
17. Patil H, Vemula SK, Narala S, et al. Hot-melt extrusion: from theory to application in pharmaceutical formulation-where are we now? AAPS PharmSciTech. 2024; 25:37. https://doi.org/10.1208/s12249-024-02749-2 PMid:38355916
18. Muley S, Nandgude T, Podczeck F. Extrusion-spheronization: a promising pelletization technique: in-depth review. Asian J Pharm Sci. 2016;11(6):684-699. https://doi.org/10.1016/j.ajps.2016.08.001
19. Vervaet C, Baert L, Remon JP. Extrusion-spheronisation: a literature review. Int J Pharm. 1995;116(2):131-146. https://doi.org/10.1016/0378-5173(94)00311-R
20. Rani S, Mastiholimath VS, Gadad AP, Dandagi PM. Development and validation of a RP-HPLC method for the determination of pregabalin in capsules. Indian J Pharm Sci. 2010;72(4):519-522. https://doi.org/10.4103/0250-474X.73935 PMid:21218069 PMCid:PMC3013579
21. Singh C, Rao K, Yadav N, Bansal N, Vashist Y, Kumari S, et al. A review: drug-excipient incompatibility by FTIR spectroscopy. Curr Pharm Anal. 2023;19(5). https://doi.org/10.2174/1573412919666230228102158
22. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123-133. https://doi.org/10.1016/S0928-0987(01)00095-1 PMid:11297896
23. Sharma R, Ranawat MS, Sayra B, Bhandar A, Chouhan CS. Statistical screening of starch paste and guar gum on hardness and disintegration time of fast dissolving tablet. Int. J. Pham. Pharm. Sci. 2012;1012(4):85-89.
24. Rambabu S, Ranawat MS, Anil B, Dinesh P. The study of guar gum and starch on disintegration time and drug release of fast dissolving tablet in rabbit using single dose randomized parallel design method. Jordan Journal of Pharmaceutical Sciences. 2013;6(3):280-291. https://doi.org/10.12816/0001506
25. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145-1149. https://doi.org/10.1002/jps.2600521210 PMid:14088963
26. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25-35. https://doi.org/10.1016/0378-5173(83)90064-9
27. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q1A(R2): Stability testing of new drug substances and products. Geneva: ICH; 2003.
Published
Abstract Display: 0
PDF Downloads: 0
PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Bhav Saraswat , Jyoti Gupta , Ram Babu Sharma

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.